scispace - formally typeset
S

Sandro Sorbi

Researcher at University of Florence

Publications -  569
Citations -  43177

Sandro Sorbi is an academic researcher from University of Florence. The author has contributed to research in topics: Frontotemporal dementia & Dementia. The author has an hindex of 82, co-authored 507 publications receiving 37504 citations. Previous affiliations of Sandro Sorbi include University of Wales & Cornell University.

Papers
More filters
Journal ArticleDOI

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease

Jean-Charles Lambert, +215 more
- 01 Dec 2013 - 
TL;DR: In addition to the APOE locus (encoding apolipoprotein E), 19 loci reached genome-wide significance (P < 5 × 10−8) in the combined stage 1 and stage 2 analysis, of which 11 are newly associated with Alzheimer's disease.
Journal ArticleDOI

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

TL;DR: Analysis of the nucleotide sequence of the open reading frame of the E5-1 gene led to the discovery of two missense substitutions at conserved amino-acid residues in affected members of pedigrees with a form of familial AD that has a later age of onset than the AD3 subtype (50–70 years versus 30–60 years for AD3).
Journal ArticleDOI

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

Paul Hollingworth, +177 more
- 01 May 2011 - 
TL;DR: Meta-analyses of all data provided compelling evidence that ABCA7 and the MS4A gene cluster are new Alzheimer's disease susceptibility loci and independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance.
Journal ArticleDOI

Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.

Valentina Escott-Price, +194 more
- 12 Jun 2014 - 
TL;DR: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimers disease.